Clinical Trials Logo

Squamous Cell Carcinoma clinical trials

View clinical trials related to Squamous Cell Carcinoma.

Filter by:

NCT ID: NCT05740774 Recruiting - Clinical trials for Head and Neck Cancer

Surgical Margin Assessment by 3D Ultrasound

Start date: January 1, 2023
Phase: N/A
Study type: Interventional

Complete removal of cancer encircled by a secure margin of healthy tissue is the aim of surgical oncology. A close or positive surgical margin reported by pathologist typically ends in adjuvant therapies (re-surgery and/or radiotherapy), which come with prognostic risks and financial cost. Therefore, ex-vivo imaging of removed cancer tissue may assist in margin evaluation. In this study, investigators aimed to investigate the correlation of 3D ultrasound to histopathology to assess tongue tumor margin status.

NCT ID: NCT05729139 Withdrawn - Clinical trials for Squamous Cell Carcinoma

Cemiplimab/Peg-Interferon-α in Advanced CSCC

Start date: July 2023
Phase: Phase 1
Study type: Interventional

The primary purpose of this research study is to test the safety and possible harms of cemiplimab/peg-interferon-alpha, when it is given to participants at different dose levels. The researchers want to find out what effects (good and bad) cemiplimab/Peg-Interferon has on participants with advanced cutaneous squamous cell carcinoma (aCSCC) so that they can find the best dose to treat aCSCC and reduce side effects as much as possible.

NCT ID: NCT05693116 Recruiting - Clinical trials for Squamous Cell Carcinoma

Survival and Prognostic Factors of Squamous Cell Carcinoma of the Nasal Vestibule

NV-SCC
Start date: December 1, 2022
Phase:
Study type: Observational [Patient Registry]

The goal of this observational study is to learn about survival and prognostic factors in patients who underwent surgical treatment for primary squamous cell carcinoma of the nasal vestibule. The main questions it aims to answer are: - what is the prognosis of patients affected by squamous cell carcinoma of the nasal vestibule? - are there any specific factors that could influence prognosis? - is it possible to elaborate a new staging system, able to overcome the limitations of the currently used ones? Data about patients, tumour and type of surgery performed will be collected. Participants will be followed-up for a minimum 6 months period after surgery.

NCT ID: NCT05681039 Recruiting - Clinical trials for Squamous Cell Carcinoma

Phase 2 Trial of Neoadjuvant and Adjuvant Tiragolumab Plus Atezolizumab in Patients With Newly Diagnosed PD-L1 CPS Positive Resectable Stage 3-4 Oral Cavity Squamous Cell Carcinoma (OCSCC).

Start date: June 2, 2023
Phase: Phase 2
Study type: Interventional

To learn if treatment with tiragolumab and atezolizumab before and after standard of care surgery and chemoradiation (radiation therapy with or without cisplatin/carboplatin) can help to control OCSCC that is PD-L1 CPS positive.

NCT ID: NCT05648604 Recruiting - Melanoma Clinical Trials

Mentored Community Gardening for Individuals With Skin Cancer

H4H2-AZ
Start date: February 2, 2023
Phase: N/A
Study type: Interventional

The investigators will conduct a single-arm pilot feasibility trial of mentored community gardening for melanoma survivors integrating dosimeters and accelerometers. Harvest for Health Together Arizona (H4H2-AZ) is an evidence-based program adapted for arid desert gardening that also addresses sun safety through group workshops and peer education. The primary aim is to evaluate adherence to the intervention.

NCT ID: NCT05610293 Active, not recruiting - Surgery Clinical Trials

T1 Squamous Cell Carcinomas of the Lip

Start date: April 1, 2021
Phase:
Study type: Observational

The purpose of this study is to investigate the risk of recurrence and metastasis in patients treated with different surgical margins (5mm vs 10mm) for a T1 squamous cell carcinoma of the lip.

NCT ID: NCT05574101 Recruiting - Clinical trials for Squamous Cell Carcinoma

A Study of Radiation Therapy and Cemiplimab for People With Skin Cancer

Start date: October 6, 2022
Phase: Phase 2
Study type: Interventional

The purpose of the study is to see if the combination of radiation therapy and cemiplimab immunotherapy is an effective treatment for people with locally advanced, unresectable CSCC.

NCT ID: NCT05535023 Withdrawn - Clinical trials for Head and Neck Cancer

Phase 2 Study of Neoadjuvant SAR444245 Plus Cemiplimab in HPV Related Oropharynx Squamous Cell Carcinoma

Start date: August 24, 2022
Phase: Phase 2
Study type: Interventional

To learn if SAR444245 given in combination with cemiplimab can help to kill cancer cells in patients with HPV-related oropharynx cancer who are scheduled to have surgery to remove the disease

NCT ID: NCT05402046 Recruiting - Melanoma (Skin) Clinical Trials

Clinical vAlidation of a MobilE appLication ("ProRodinki") in the Assessment of the maLignant skIn neoplAsms

CAMELLIA
Start date: April 23, 2022
Phase: N/A
Study type: Interventional

A Multicenter, Prospective, Low-interventional Clinical Study Evaluating on mobile application validation ("ProRodinki") in assessing the risk of skin malignant neoplasms

NCT ID: NCT05340543 Recruiting - Melanoma Clinical Trials

Ex-vivo Examination of Excisions of Skin Tumors by Confocal Optical Coherence Tomography (LC-OCT) With Integrated Dermoscopy and Comparison With Histology (DERMOCTAV)

DERMOCTAV
Start date: December 16, 2021
Phase:
Study type: Observational

This project aims to validate ex vivo the use of the OCTAV® prototype integrating the "dermoscope" function before an in vivo application, by comparing images obtained by the OCTAV® prototype integrating the "dermoscope" function with the histological sections of a skin tumor excision corresponding to them exactly, at the same level.